FDA Approves RU-486
WASHINGTON - The Food and Drug Administration (FDA) approved the abortion pill RU-486. Within a month, doctors will be able to prescribe the drug Mifeprex, or mifepristone, for women who are as much as seven weeks pregnant.
Despite warnings that the FDA would impose limitations on doctors who offer the pill, yesterdays approval came with relatively minor restrictions. The rules given require that doctors who prescribe Mifeprex be able to determine how far along a pregnancy is and must either be able to perform surgical abortions or have a pre-existing agreement with another physician who is qualified to conduct such surgery. For more information visit www.fda.gov.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.
